PaperPlayer biorxiv biochemistry

SUMO Modifies GβL and Mediates mTOR Signaling


Listen Later

Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2020.09.03.281881v1?rss=1
Authors: Park, S. L. L., Ramirez Jarquin, U. N., Shahani, N., Rivera, O., Sharma, M., McManus, F. P., Thibault, P., Subramaniam, S.
Abstract:
The mechanistic target of rapamycin (mTOR) signaling is influenced by multiple regulatory proteins and post-translational modifications, however, underlying mechanisms remains unclear. Here, we report a novel role of small ubiquitin-like modifier (SUMO) in mTOR complex assembly and activity. By investigating the SUMOylation status of core mTOR components, we observed that the regulatory subunit, G{beta}L, is modified by SUMO1, 2, and 3 isoforms. Using mutagenesis and mass spectrometry, we identified that G{beta}L is SUMOylated at lysine sites K86, K215, K245, K261 and K305. We found that SUMO depletion reduces mTOR-Raptor and mTOR-Rictor complex formation and diminishes nutrient-induced mTOR signaling. Furthermore, we found that reconstitution with WT G{beta}L but not SUMOylation defective KR mutant G{beta}L promote mTOR signaling in G{beta}L-depleted cells. Taken together, we report for the very first time that SUMO modifies G{beta}L, influences the assembly of mTOR protein complexes, and regulates mTOR activity.
Copy rights belong to original authors. Visit the link for more info
...more
View all episodesView all episodes
Download on the App Store

PaperPlayer biorxiv biochemistryBy Multimodal LLC